Web Results

Mattern Pharmaceuticals / The Nasal Company ... - MetP Pharma AG

mattern-pharma.com/news.php

November 2015. Start of clinical Phase IIa trial with MetP's Progesterone vs. Zolpidem in women suffering from Insomnia Disorder.

These 3 Ugly Patent Battles Could Rock Biopharma's 2017 - Fortune

fortune.com/2017/01/07/amgen-sanofi-patent-rulings-2017/

Jan 7, 2017 ... These 3 Ugly Patent Battles Could Rock Biopharma's 2017 ... Amgen vs Sanofi/ Regeneron ... CRISPR gene-editing pioneers vs each other.

Auxilium Loses Testim Patent Claims Against Upsher-Smith - Law360

www.law360.com/articles/493428/auxilium-loses-testim-patent-claims-against-upsher-smith

Dec 4, 2013 ... Auxilium Pharmaceuticals Inc. lost a patent infringement suit Wednesday ... gel for men infringed 10 patents related to Auxilium's Testim gel, when a ... when an accused product or process embodies every limitation of a claim, ...

Allergan Triumphs In Suits Over Generic Combigan - Law360

www.law360.com/articles/266706/allergan-triumphs-in-suits-over-generic-combigan

Aug 22, 2011 ... Allergan obtained the four asserted patents, all titled “Combination of ... pressure in patients with open-eye glaucoma or ocular hypertension. ... Novartis AG subsidiary Sandoz over its attempts to market a generic Combigan.

Patents VS Innovation | UAEM Evidence

uaemevidence.wordpress.com/category/patents-vs-innovation/

A liberal economists perspective on why patents may not promote innovation. ... in Patents VS Innovation, SRL, Universities vs Industry · Leave a comment ...

Cellectis patent surprises biopharma, could block CRISPR

www.biopharma-reporter.com/Markets-Regulations/Cellectis-patent-surprises-biopharma-could-block-CRISPR

Jan 9, 2015 ... A patent issued to French biotech Cellectis threatens to block gene ... Intellia or DuPont Industrial Biosciences (which work with CRISPR), ...